Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (12)
- (-) Climate Change (10)
- (-) Molten Salt (1)
- (-) Transportation (4)
- 3-D Printing/Advanced Manufacturing (12)
- Advanced Reactors (4)
- Artificial Intelligence (16)
- Big Data (4)
- Bioenergy (13)
- Biology (19)
- Biotechnology (5)
- Buildings (4)
- Chemical Sciences (9)
- Composites (3)
- Computer Science (37)
- Coronavirus (11)
- Critical Materials (1)
- Cybersecurity (8)
- Decarbonization (5)
- Energy Storage (10)
- Environment (22)
- Exascale Computing (10)
- Frontier (15)
- Fusion (2)
- Grid (4)
- High-Performance Computing (20)
- Isotopes (4)
- Machine Learning (7)
- Materials (21)
- Materials Science (20)
- Microscopy (8)
- Nanotechnology (14)
- National Security (5)
- Net Zero (1)
- Neutron Science (43)
- Nuclear Energy (12)
- Partnerships (5)
- Physics (11)
- Polymers (1)
- Quantum Computing (5)
- Quantum Science (15)
- Security (4)
- Simulation (7)
- Software (1)
- Space Exploration (3)
- Summit (17)
- Sustainable Energy (9)
- Transformational Challenge Reactor (2)
Media Contacts
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
Researchers used neutrons to probe a running engine at ORNL’s Spallation Neutron Source